Freedom of Information request about adverse drug reactions (ADR) to Covid-19 vaccines (FOI-21-365)
Published 28 May 2021
© Crown copyright 2021
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-12-april-2021/freedom-of-information-request-about-adverse-drug-reactions-adr-to-covid-19-vaccines-foi-21-365
Thank you for your email.
The Agency is funded mainly from fees and sales from multiple, diverse and global sources, with the remainder of funds coming from Central Government or research funding.
The amount of funding received from central government can be found on our annual reports.
19/20 = https://www.gov.uk/government/publications/medicines-and-healthcare-products-regulatory-agency-annual-report-and-accounts-2019-to-2020
Our financial year runs from 1st April to 31st March so 20/21 accounts are not yet available.
Yours sincerely
MHRA Customer Service Centre
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU